课题基金 / 基金详情

IGF::OT::IGF - Gene Therapy Resource Program (GTRP) Lentivirus Vector Production

IGF::OT::IGF - Gene Therapy Resource Program (GTRP) Lentivirus Vector Production
IGF::OT::IGF - 基因治疗资源计划 (GTRP) 慢病毒载体生产
批准号：
8862323
负责人：
KENNETH CORNETTA
金额：
$6.0万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
项目状态：
已结题
起止时间：
2012-06-01 至 2017-05-31
来源：
https://reporter.nih.gov/project-details/8862323
关键词：
Animal ModelClinicalClinical ResearchContractorContractsDoseFundingGene TransferLaboratoriesLentivirus VectorNational Heart, Lung, and Blood InstitutePharmacology and ToxicologyProductionRegulationResearch PersonnelResourcesSafetyTestingUnited States Food and Drug Administrationgene therapyprogramsvector

项目摘要

项目成果

KENNETH CORNETTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Lentiviral vector production core laboratory contract involves production of scalable clinical grade Lentiviral vectors, in accordance with Good Manufacturing Practices (GMP), as defined by the Food and Drug Administration (FDA), and applicable State and Federal regulations, for use by NHBLI funded investigators. It is expected that the contractor will produce an average of Twelve (12) vector batches per year for a minimum of three (3) batches for clinical studies or for safety and efficacy/dose/pharmacology/toxicology testing with large animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel approach to Mesenchymal Stem Cell Transduction
  • 批准号：
    10325618
  • 项目类别：
  • 资助金额：
    $24.85万
  • 财政年份：
    2021
  • 负责人：
    KENNETH CORNETTA
  • 依托单位：
    OSSIUM HEALTH, INC.
NATIONAL GENE VECTOR BIOREPOSITORY AND COORDINATING CENTER (NGVB): TASK AREA B, CORE SCIENTIFIC ACTIVITIES FOR NCI
NATIONAL GENE VECTOR BIOREPOSITORY AND COORDINATING CENTER (NGVB): TASK AREA B, CORE SCIENTIFIC ACTIVITIES FOR NCI
PURPOSE OF THE NGVB CONTRACT IS TO CONTINUE SUPPORTING GENE THERAPY RESEARCH.
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data